新闻中心
OCI-LY10: The “Golden Key” to Unlocking BTK Inhibitor Resistance
Kyinno Biotechnology
09.02.2026
Unlocking the Key to Neurodegenerative Diseases: In-Depth Analysis of Target MAPT and the Tet-On Precision Regulation System
Kyinno Biotechnology
09.02.2026
Stunning Data of RMC6236 Combined with PD1 Immunotherapy in CT26-KRAS-G12C-KI Model
Kyinno Biotechnology
29.01.2026
Antibody Discovery Technologies: Comparing Methods to Find the Best Fit for Your Project
Kyinno Biotechnology
18.08.2025
Preventing Off-Target Binding in Antibody Discovery: Strategies for Specificity
Kyinno Biotechnology
04.08.2025
Antibody Discovery 101: Core Concepts Every Biotech and Diagnostic Team Should Know
Kyinno Biotechnology
25.07.2025
From Target to Therapy: Understanding the Antibody Discovery Process in Modern Drug Development
Kyinno Biotechnology
21.07.2025
Demystifying Drug Synergy: How Bliss, Loewe, and ZIP Models Compare
Kyinno Biotechnology
24.11.2025
Winning Against Resistance: Drug Combination in Infectious Disease Research
Kyinno Biotechnology
21.11.2025
Innovation in Rare Diseases: The Promise of Combination Therapy Approaches
Kyinno Biotechnology
17.11.2025
Tackling Tumors: How Drug Combinations are Changing Oncology Research
Kyinno Biotechnology
07.11.2025
Predicting Drug Success: The Role of AI in Modern Screening
Kyinno Biotechnology
03.11.2025